Coronavirus Update - 09th November 2020

We would like to reassure our customers that as England enters its second national lockdown period, we remain open for business and at full capacity as we have done since the start of this pandemic and fully comply with all government guidance on minimising the risks of COVID-19.

As the situation continues to evolve, we will keep all our customers and stakeholders informed of our activities through this web-page which is updated on a regular basis.

Join Arcinova and Covance for our next ADME/Human AME Virtual Symposium

Join Arcinova and Covance for our next ADME/Human AME Virtual Symposium

Where experts will share insights in an interactive dialogue, exploring new approaches for optimizing your next ADME/hAME study. Key Questions (But Bring Your Own Questions Too!)

  • Why are ADME/human AME (hAME) studies required?
  • What are the regulatory requirements?
  • What are the pharmacy and radiosynthesis challenges?
  • What are the benefits to using an integrated preclinical to clinical approach?

There are three sessions available, please click here to book your place

 




Discover how Arcinova can help

We provide a fully integrated approach to drug development, speak to our team and discover how we can help you fast forward to market.

GET IN TOUCH